Fig. 1. SC66 inhibits RCC cell progression in vitro.

786-O RCC cells (a–f), primary human RCC cells (“RCC1/RCC2/RCC3”, g–i), or HK-2 tubular epithelial cells (j–l), the primary human renal epithelial cells (“Ren_Epi”) (j–l) were treated with indicated concentration of SC66, cells were further cultured for applied time periods, cell functions, including cell survival, proliferation, migration and invasion were tested by the appropriate assays. For each assay, n = 5. Data were expressed as the mean ± standard deviation (S.D.). *P < 0.05 vs. DMSO (0.1%) vehicle (“Veh”, same for all Figures). In this figure, experiments were repeated three times, and similar results were obtained each time. Bar = 100 μm (d–f, h).